Contact Point for People Involved in Clinical Trials
The address of the contact point at the Paul-Ehrlich-Institut for people involved in a clinical trial, their legal representative or one of their authorised representatives, pursuant to section 40 sub-section 5 AMG, is as follows:
Federal Institute for Vaccines and Biomedicines
Please quote the reference “Clinical trials” on written enquiries by letter.
Please note that pursuant to section 77 sub-section 2 of the Medicinal Product Act, the Paul-Ehrlich-Institut is the competent authority for sera, vaccines, blood preparations, bone marrow preparations, allergens, test sera, test antigens, gene transfer medicinal products, somatic cell therapeutics, xenogenic cell therapeutics and genetically manufactured blood components.
The Federal Institute for Drugs and Medical Devices (BfArM) in Bonn is the competent authority for all other medicinal products.